Product Information
DROSPIRENONE-EE 3-0.03 MG TAB is a generic product labeled by Lupin Pharmaceuticals Inc., priced at $0.1492 per EA under NDC 68180086873. Its NADAC has been published 204 times since Sep 28, 2022.
FDA first approved this application on Dec 18, 2012. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Manufacturer
Lupin Pharmaceuticals Inc.NDC
68180086873
Classification
Generic
Dosage Form
KIT
Effective Date
8/19/2026
Approval Type
Generic (ANDA)
FDA Application
ANDA201663FDA Approved
12/18/2012
TE Code
AB
On Market Since
4/15/2022
Price Statistics
The NADAC for DROSPIRENONE-EE 3-0.03 MG TAB has been published 204 times since Sep 28, 2022, and over the history we have for it it has declined 29.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1492 per EA |
|---|---|
| All-time high | $0.2248 (Nov 16, 2022) |
| All-time low | $0.1445 (Jul 22, 2026) |
| 52-week high | $0.1731 |
| 52-week low | $0.1445 |
| Median price | $0.1773 |
| Average price | $0.1774 |
| Largest weekly change | +27.6% (Jun 19, 2024) |
| Weeks tracked | 204 |
| Tracking since | Sep 28, 2022 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the DROSPIRENONE AND ETHINYL ESTRADIOL market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of DROSPIRENONE-EE 3-0.03 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for DROSPIRENONE-EE 3-0.03 MG TAB, manufactured by Lupin Pharmaceuticals Inc., is $0.1492 per EA (NDC 68180086873), effective Aug 19, 2026.
How has the price of DROSPIRENONE-EE 3-0.03 MG TAB changed over time?
Over the history we have for it, the NADAC for DROSPIRENONE-EE 3-0.03 MG TAB has declined 29.6%. It has been tracked across 204 weekly CMS publications since Sep 28, 2022.
What are the highest and lowest recorded NADAC prices for DROSPIRENONE-EE 3-0.03 MG TAB?
Since Sep 28, 2022, the NADAC for DROSPIRENONE-EE 3-0.03 MG TAB has ranged from a low of $0.1445 (Jul 22, 2026) to a high of $0.2248 (Nov 16, 2022), with a median of $0.1773 per EA.
Are there cheaper alternatives to DROSPIRENONE-EE 3-0.03 MG TAB?
No other NADAC-published product currently shares the active ingredient and strength of DROSPIRENONE-EE 3-0.03 MG TAB in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures DROSPIRENONE-EE 3-0.03 MG TAB?
DROSPIRENONE-EE 3-0.03 MG TAB (NDC 68180086873) is labeled by Lupin Pharmaceuticals Inc., and CMS classifies it as a generic product.